Birth-dose Hepatitis B Vaccine and Bronchopulmonary Dysplasia Risks in Preterm Infants
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Wyckoff M, Wyllie J, Aziz K, de Almeida M, Fabres J, Fawke J
. Neonatal Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation. 2020; 142(16_suppl_1):S185-S221.
DOI: 10.1161/CIR.0000000000000895.
View
2.
Remschmidt C, Wichmann O, Harder T
. Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic review. BMC Infect Dis. 2015; 15:429.
PMC: 4609091.
DOI: 10.1186/s12879-015-1154-y.
View
3.
Nie X, Xu L, Bai Y, Liu Z, Liu Z, Farrington P
. Self-controlled case series design in vaccine safety: a systematic review. Expert Rev Vaccines. 2021; 21(3):313-324.
DOI: 10.1080/14760584.2022.2020108.
View
4.
McNeil M, Gee J, Weintraub E, Belongia E, Lee G, Glanz J
. The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety. Vaccine. 2014; 32(42):5390-8.
PMC: 6727851.
DOI: 10.1016/j.vaccine.2014.07.073.
View
5.
Laughon M, Langer J, Bose C, Smith P, Ambalavanan N, Kennedy K
. Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants. Am J Respir Crit Care Med. 2011; 183(12):1715-22.
PMC: 3136997.
DOI: 10.1164/rccm.201101-0055OC.
View